氟伐他汀和非诺贝特治疗糖尿病合并高血脂的临床疗效分析

Analysis of Clinical Efficacy of Fluvastatin and Fenofibrate in the Treatment of Diabetes Mellitus With Hyperlipidemia

目的探析氟伐他汀联合非诺贝特治疗糖尿病合并高血脂的临床疗效。方法选取北方医院2012年2月~2014年6月糖尿病合并高血脂患者92例,将其随机分为对照组（46例）和观察组（46例）,其中对照组单独采取氟伐他汀治疗,观察组患者采取氟伐他汀联合非诺贝特治疗。结果两组患者治疗前TC、TG、LDL-C、HDL-C和2 h PG差异无统计学意义（P〉0.05）,治疗后观察组患者以上各数据均优于对照组患者（P〈0.05）。结论采用氟伐他汀联合非诺贝特治疗糖尿病合并高血脂,能够有效改善患者的血糖和血脂水平。

Objective To analysis the fluorine cut statin combination of fenofibrate clinical curative effect for the treatment of diabetic dyslipidemia. Methods 92 cases of diabetic patients with high blood lipids were selected in the Northern Hospital from February 2012 to June 2014, will be randomly divided into control group（46 cases） and observation group（46 cases）, including control group take fluorine cut statin therapy alone, observation group of patients taking statin combination therapy with fenofibrate fluorine. Results The two groups of patients before treatment TC, TG, LDL-C, HDL-C and 2 h PG difference was not statistically significant（P〈0.05）, after treatment observation group patients above each data were better than the control group patients（P〈0.05）. Conclusion Using fluorine cutting atorvastatin combined with fenofibrate in treatment of diabetes combined with hyperlipidemia, can effectively improve the patient＇s blood glucose and lipid levels.